PREVENTION AND TREATMENT OF OXIDATIVE STRESS DISORDERS BY GLUTATHIONE AND PHASE II DETOXIFICATION ENZYMES

Details for Australian Patent Application No. 2002357311 (hide)

Owner JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

Inventors TALALAY, Paul; GAO, Xiangqun; DINKOVA-KOSTOVA, Albena, T.

Pub. Number AU-A-2002357311

PCT Number PCT/US02/40457

PCT Pub. Number WO2003/051313

Priority 60/340,273 18.12.01 US

Filing date 18 December 2002

Wipo publication date 30 June 2003

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/340,273 18.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002357311

2 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357312-BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-ALPHA CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES

2002357310-MEDICAL LEAD AND LEAD CONNECTOR SYSTEM